Barclays
MXCT icon

Barclays’s MaxCyte MXCT Stock Holding History

Barclays’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$183K Sell
149,013
-14,049
-9% -$14K ﹤0.01% 3767
2026
Q1 		$115K Sell
163,062
-137,218
-46% -$128K ﹤0.01% 3972
2025
Q4 		$465K Buy
300,280
+8,639
+3% +$13.8K ﹤0.01% 3894
2025
Q3 		$461K Sell
291,641
-29,590
-9% -$51.4K ﹤0.01% 3861
2025
Q2 		$700K Buy
321,231
+206,459
+180% +$500K ﹤0.01% 3565
2025
Q1 		$313K Sell
114,772
-49,260
-30% -$194K ﹤0.01% 3810
2024
Q4 		$682K Sell
164,032
-1,733
-1% -$6.55K ﹤0.01% 3636
2024
Q3 		$645K Buy
165,765
+127,156
+329% +$536K ﹤0.01% 3620
2024
Q2 		$151K Sell
38,609
-40,623
-51% -$175K ﹤0.01% 3720
2024
Q1 		$332K Sell
79,232
-58,599
-43% -$275K ﹤0.01% 3837
2023
Q4 		$648K Buy
137,831
+106,266
+337% +$414K ﹤0.01% 3717
2023
Q3 		$98.5K Sell
31,565
-3,359
-10% -$13.5K ﹤0.01% 3606
2023
Q2 		$160K Sell
34,924
-42,954
-55% -$197K ﹤0.01% 3354
2023
Q1 		$385K Buy
77,878
+47,281
+155% +$233K ﹤0.01% 3442
2022
Q4 		$167K Buy
30,597
+19,377
+173% +$119K ﹤0.01% 3949
2022
Q3 		$72K Sell
11,220
-1,572
-12% -$8.77K ﹤0.01% 3660
2022
Q2 		$61K Sell
12,792
-20,437
-62% -$101K ﹤0.01% 3963
2022
Q1 		$233K Buy
33,229
+32,039
+2,692% +$219K ﹤0.01% 3329
2021
Q4 		$12K Sell
1,190
-29
-2% -$311 ﹤0.01% 3985
2021
Q3 		$15K Buy
+1,219
New +$18.4K ﹤0.01% 4452

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Barclays's MXCT Position: Q2 2026 in Review

Barclays reduced its MaxCyte (MXCT) stake by 8.6% in Q2 2026, selling an estimated $14K and leaving 149,013 shares worth $183K. The position accounts for ﹤0.01% of the portfolio, ranked #3767.

Barclays first reported a position in MXCT in Q3 2021 and has held it in 20 quarters since. The position peaked at $700K in Q2 2025. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Barclays held 149,013 shares of MaxCyte worth $183K as of Q2 2026.
  • Barclays sold 14,049 MaxCyte shares in Q2 2026, an estimated $14K.
  • MaxCyte made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3767 holding.
  • Barclays first reported a position in MaxCyte in Q3 2021 and has held it in 20 quarters since.
  • Barclays's MaxCyte position peaked at $700K in Q2 2025.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.